Due to case number limited case numbers, we were not able to resolve the underlying difference in PRSS23 and ERα across the various subtype that could help to subtype breast cancers with distinct prognostic outcomes; however, we were able to validate the association between ERα status and high PRSS23 expression with statistical confidence. This evidence concerns the gene ESR1 and breast carcinoma.